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ABSTRACT 
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Apoptosis is a physiological cell death program that is characterized by 
morphological changes such as nuclear condensation, membrane blebbing, cell 
shrinkage, DNA cleavage and formation of apoptotic bodies. It is  required for 
normal development and maintenance of cellular homeostasis and  
dysregulation of apoptosis leads to several developmental abnormalities, 
progression of degenerative diseases and cancer development. Elucidating the 
mechanisms underlying this form of cell death and development of molecular 
markers for its identification are of great importance to understand 
tumorigenesis. 
One way to generate molecular markers is based on monoclonal antibody-
production. Utilization of such antibodies as apoptotic markers is strictly 
dependent on their molecular specificity and selectivity in terms of recognizing 
targeted proteins.  
We produced monoclonal antibodies by using apoptotic Huh-7 
hepatocellular carcinoma cells as immunogen, and chose two of them, namely 
9C11 and 6D5 for further characterization in the context of apoptosis.  
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ÖZET 
HİBRİDOMA TEKNOLOJİSİ KULLANILARAK YENİ APOPTOTİK 
BELİRTEÇLERİN TANIMLANMASI 
 
Apoptoz hücre büzüşmesi, çekirdek yoğunlaşması, hücre zarı tomurcuklanması, 
DNA kırpılması ve apoptoz cisimciklerinin oluşması ile tanımlanan fizyolojik 
bir hücre ölüm programıdır. Bu program normal gelişimin ve hücresel 
homeostazinin sürekliliği için gerekli olup, bozukluğu koşullarında gelişimsel 
anomalilere, dejeneratif hastalıklara ve kanser gelişimine neden olmaktadır. Bu 
hücre ölüm biçiminin altında yatan mekanizmaları aydınlatmak ve tanımlanması 
için gerekli moleküler belirteçleri geliştirmek tümör oluşunu anlamak açısından 
çok büyük öneme sahiptir. 
Moleküler belirteçleri geliştirmenin bir yolu monoklonal antikorların 
üretilmesidir. Bu tür antikorların apoptoz belirteci olarak kulanılması, 
hedeflenen proteinleri seçici ve özgül olarak tanımalarına bağlıdır. 
Apoptoz tetiklenmiş, hepatoselüler karsinom hücre dizisi, Huh7 hücrelerini 
immünojen olarak kullanıp monoklonal antikorlar geliştirdik ve bunlardan 9C11 
ve 6D5 antikorlarını, apoptoz kapsamında daha ileri tanımlanmaları için seçtik.  
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1. INTRODUCTION 
 
 
1.1 Apoptosis 
  
Apoptosis is a physiological cell death program that was first described in 
modern scientific world by the article of Kerr, Wyllie and Currie (1972). Apparently, 
apoptosis was chosen for its meaning of falling of leaves in ancient Greek (Kerr et al, 
1972). 
Apoptosis is a programmed cell death process that is necessary for eliminating 
cells which are no longer needed and a fundamental biological process required for 
normal development and homeostasis in multicellular organisms (Wyllie, 1980). 
Dysregulation of apoptosis causes some developmental abnormalities and diseases. 
Morphologically, apoptosis is defined by cell shrinkage, membrane blebbing, DNA 
cleavage and the formation of apoptotic bodies (Miller et al., 2001). Apoptosis is 
distinguished from necrosis by these features. Transition from normal to shrunken 
form and blebbing are rapid, typically take 10-30 minutes, and at that point apoptotic 
cells are phagocytosed either by their nearest neighbors or by professional 
macrophages (Zörnig et al., 2001). 
In contrast, necrotic cells initially increase their cellular water content and by 
this way they also increase their volume. The nuclei lose the typical chromatin 
structure, which is seen as irregular clumping or dissolution and cell membrane 
ruptures, secretes the cellular contents into the environment. There are some criteria 
for distinguishing apoptosis from necrosis.  
Table 1: Comparison of apoptotic and necrotic cells  (Richter, 1993; Studzinski, 
1999). 
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 Apoptosis Necrosis 
Nuclei Dense condensation of 
chromatin 
Karyolysis is preceded by 
irregular chromatin 
clumping 
Cytoplasmic organelles Morphologically intact Disrupted 
Cell membrane Apoptotic bodies, blebbing Blebbing and loss of 
integrity 
Cell volume Cells shrinks Cells swell 
In tissues Single cell affected Groups of cells affected 
Tissue response None Inflammation 
 
 
  
1.2 Apoptotic pathways 
 
  Apoptosis takes place in two ways: 
i) The death receptor (DR) or extrinsic pathway 
ii) The mitochondrial or intrinsic pathway.  
 
External signals or internal signals come and activate a initiator proteases, 
which subsequently activate the amplifier caspases, causing the activation of effective 
proteases. Sequential activation of succesive proteases (caspases) provides a fail-safe 
mechanism that makes possible to abort a premature apoptotic signal and it also 
serves to amplify the signal to lead rapid finalization of an irrevocable decision to self 
destruct ( Studzinski, 1999).  
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Death receptor pathway involves oligomerization of cell surface receptors to 
trigger the apoptotic pathway. Liver cells generally express DRs perhaps due to 
evolutionary pressure to omit hepatotropic viruses.  
Mitochondrial pathway  is mediated by DNA damage, changes of intracellular 
Ca+2, and endoplasmic stress response (Yoon et al., 2002). Many types of cellular 
stress, including starvation, oxidative damage cause initiation of intrinsic pathway 
where caspase activation follows signals transduced at the level of the mitochondria. 
(Özören et al., 2002).  
 
Activated molecular pathways differ according to DNA damage type, 
meaning that the nature of DNA structure recognized by the sensors defines the steps 
to follow. Depending on their functions within the signaling cascade, there are three 
types of proteins called sensors, transducers and effectors. Sensors are involved in 
DNA damage response and detect the damage, transducers transmit the signal where 
damage is present and effectors elicit the various specific biological responses 
(Stergiou et al., 2004).  
 
 
 
 
Extrinsic pathway (apoptosis via death receptor) 
 
DRs are cell surface receptors belonging to the tumor necrosis factor (TNF) 
receptor superfamily and trigger apoptosis after binding to their ligands or in 
experimental conditions, agonistic antibodies (Ashkenazi, 2002). TNF was isolated 
more than 15 years ago and reported to have the  ability to kill tumor cells in vitro 
(Schulze-Osthoff et al,1998). TNF is a pleitropic cytokine that is  predominantly 
produced by macrophages and T cells. It induces proliferation, displays cytolytic  
activity against tumor cells and also induces inflammatory responses and regulates 
immun responses. TNF mediates its biological effect through TNFR-I and TNFR-II 
(Gupta, 2001). DRs share a significant homology. They all have an extracellular 
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ligand-binding domain, and 60-80 amino acid cytoplasmic sequence known as the 
death domain. They differ in their cytoplasmic domains. TNFR-I contains DD (Death 
Domain), whilst TNFR-II does not. TNFRs do not display enzymatic activity, and 
thus they have to depend on recruitment of other adapter molecules for signaling 
(Gupta, 2001). 
 
 
 
 
 
          
 
Figure 1:  Death receptor structure (Yoon et al., 2002).  
 
 
 
There are six known  DRs that are reported. Fas (CD95), Tumor necrosis 
factor receptor 1(TNF-R1), Tumor necrosis factor related  apoptosis inducing ligand 
(TRAIL) receptor 1 (DR4), TRAIL2 (DR5), DR3 (APO3) and DR6. Among these six 
death receptors, apoptosis signaling  pathways  mediated by Fas, TNF-R1 and TRAIL 
receptors  have roles in the apoptosis that occurs in the liver. Pro-apoptotic signaling 
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is similar in all known death receptors. As mentioned above, after the binding of the 
ligand or specific agonistic antibody, DRs are oligomerized which leads to the 
recruitment of the cytoplasmic adapter protein. There are two major classes of  
adaptor molecules: 1) TRAFs and 2) FADD molecules. They both contain  a death 
effector domain (DED) causing the recruitment of caspases via the association with a 
corresponding death effector domain in the  prodomain of the inactive initiator 
caspases, caspase 8 and 10. The selective recruitment of  adapter molecules is 
determined according to whether they contain a DD or TRAF binding motif 
(Kasibhatla et al., 2003). 
 
The final complex is called death-inducing signaling complex (DISC). TNF-R1 and 
TRAIL R1-R2 receptors are activated as defined above. Death receptor mediated 
apoptosis can be  regulated at the level of DISC formation.(Yoon et al., 2002) 
 
Intrinsic pathway (apoptosis via mitochondria) 
 
Mitochondria are composed of two well-defined compartments: the matrix, 
surrounded by the inner membrane and the intermembrane space, surrounded by the 
outer membrane. The inner membrane contains various molecules such as ATP 
synthase, electron transport chain proteins etc. Under normal conditions, these 
molecules provide an electrochemical gradients (membrane potential). The outer 
membrane contains a voltage- dependent anion channel. The intermembrane space 
contains cytochrome-c, procaspases, apoptosis-inducing factor (AIF). 
Permeabilization of the outer membrane during apoptosis results in the releases of 
cytochrome-c (Figure 2) (Gupta, 2001). 
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Figure 2: Intrinsic pathway (Goel and Khanduja, 1998) AIF: apoptosis inducing 
factor; Cyt C: cytochrome C; Ca++: calcium; ROS: reactive oxygen species; PS: 
phoshatidylserin; PC: phoshatidylcholine). 
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The primary event is the initiation of cytochrome c release from the 
intermembrane space of mitochondria into the cytoplasm where it makes a complex 
with Apaf 1 and procaspase 9, called “apoptosome”. Initiator procaspase 9 becomes 
active and then activates other downstream effector caspases (Özören et al., 2002). 
 
Caspases have primary roles in apoptotic pathways. In this respect, caspases 
certainly constitute the key effector molecules that are required for in most apoptotic 
pathways. They are cysteine proteases, which cleave their subsrates after an Asp 
residue. All caspases are synthesized as zymogens that need to be proteolytically 
cleaved. Active enzyme is composed of a  heterotetrameric complex of two large 
subunits of approaximately 20 kDa containing the active center and two small 
subunits of 10 kDa (Figure 3) (Schulze-Osthoff et al.,1998).  
 
 
 
Figure 3: Caspase proenzyme organization (Nicholson, 1999). 
 
 
There are 11 caspases in the human genome. Eight of the human caspases 
(caspases 2, 3, 6, 7, 8, 9, 10, and 14) function in apoptosis. Two processes lead to the 
conversion of a latent apoptotic caspase to the enzymatically active form: 1) binding 
to a caspase activator protein (e.g. Apaf-1) and 2) proteolytic cleavage by another 
active caspase. Caspases function in cells in a hierarchical order involving “upstream” 
activator caspases (e.g. caspases 8, and 9) that cleave and activate “downstream” 
effector caspases (e.g. caspases 3 and 7). In addition, the caspases are divided 
between two different apoptosis pathways: 1) the death receptor or “extrinsic” 
pathway in which caspase 8 is the upstream activator caspase; and 2) the 
mitochondrial or “intrinsic” pathway in which caspase 9 is the upstream activator 
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caspase. The death receptor and mitochondrial pathways converge at the level of the 
downstream effector caspases. It has been reported that both pathways are capable of 
operating in most cell types (Degterev et al., 2003). 
 
Subgroups of Caspases 
ICE-subfamily                          Caspase-1, 4,5,11,12,13,14 
Ced3/CPP32 subfamily            Caspase-3,6,7 
ICH-1/Nedd2 subfamily           Caspase –2,8,9,10 
 
 
One of the primary regulators of intrinsic way of apoptosis is the family of 
Bcl-2 proteins. Bcl-2 family proteins play critical roles in the regulation of 
programmed cell death. Changes in the level or bioactivities of these proteins are 
associated with a variety of physiological processes where cell death occurs, 
including fetal development, normal cell turn over in epidermis and immune cell 
differentions etc (Reed, 1998;Adam and Corry, 1998). These proteins are classified 
into proapoptotic members that include Bax, Bak, Bik, Bad, Bid and anti-apoptotic 
proteins such as Bcl-2 and Bcl-xL based on their ability to suppress or induce the 
release of cytochrome c. 
 
Although they have opposing activities, all members of the Bcl-2 family 
proteins contain at least one of the four so-called BH domain (BH1-BH4). 
Proapoptotic members contains BH3 domain. For example, Bid is a proapoptotic 
protein that functions to facilitate the activity of other members of the proapoptotic 
family such as Bax and Bak. The BH3 domain of Bid mediates interaction between 
various members of the Bcl-2 family to generate a number of heterodimers and 
homodimers (Kasibhatla et al., 2003). 
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 Figure 4:  Two principal pathways of apoptosis signal transduction (Schulze-
Osthoff et al.,1998) 
 
There is a considerable cross talk between extrinsic and intrinsic pathways. 
For example, caspase 8 can proteolytically activate Bid, which can then lead to 
release of cytochrome c (Green, 2000). This apparently increases the apoptotic signal 
following death receptor activation (Fulda et al., 2001). 
 
 
 1.3 Endogenous inhibitors of apoptosis 
 
As mentioned above Bcl-2 family members have proapoptotic and anti-
apoptotic roles during apoptosis. It has been reported that Bcl-2 and Bcl-xL inhibit 
cytochrome-c release.   In addition to anti-apoptotic Bcl-2 family members, there are 
some other inhibitors of apoptosis (Gupta, 2001). The inhibitors of apoptosis protein 
family (IAP) consist of Neural Inhibitor of Apoptosis Protein (NIAP), X-linked 
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Inhibitor of Apoptosis Protein (X-IAP), survivin, c-IAP1, c-IAP2 (Deveraux and 
Reed, 1999). IAPs contain 70 amino-acid motifs termed the BIR (Baculovirus IAP 
Repeats) domain. IAPs inhibit apoptosis by inhibiting caspase activity through the 
interaction with caspase 3, 7, 9 but not caspase 1, 6, 8 or 10. XIAP contains the 
second BIR domain (BIR2), which inhibits caspase 3 and 7 (Gupta 2001). Recently 
heat shock protein 70 has been reported to have an inhibitory effect on apoptosis 
(Jaattela et al., 1998). Survivin is another apoptosis inhibitory protein that has 
structural similarity to IAPs and the only apoptosis inhibitor protein expressed 
selectively in most human cancers but lacking from normal adult tissue. 
 
 
 
 
 
 
1.4 Oxidative stress  
 
Recent studies indicate that apoptosis can be induced  by exogenous oxidants 
(Hockenbery et al.,1993). Several lines of evidence support a role for oxidative stress 
as a mediator of apoptosis. Both ionizing radiation, which generates reactive oxigen 
species (ROS) and H2O2 treatment  can cause apoptosis.  
H2O2 causes dose and time dependent reduction of survival of hepatoma cells 
and also resulted in an increase in the number of detaching cells from the surface of 
the culture dish. Loss of adhesion is the feature of apoptotic cells and results in a 
morphological changes. H2O2  may destroy Ca2+ homeostasis, damage membrane 
receptors and activate signal transduction system and lead to the apoptosis. Exposure 
to H2O2 causes a decrease in levels of Bcl-2 protein in some hepatoma cells (Li et 
al.,2000). 
 
1.5 Apoptosis detection methods 
 
Apoptosis is distinguished morphologically from necrotic, non-apoptotic cells 
by some features as mentioned above. Detection of apoptosis in cells and tissues is 
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an important issue both to study the molecular mechanism of apoptosis and roles of 
apoptosis in diseases. To detect apoptosis, apoptotic features such as activation of 
death receptors, formation of cytochrome c/Apaf-1 complex, caspase activation, 
phosphotidylserine exposure, DNA laddering, morphological changes are considered 
 
 
 
 
 
Analysis of morphological changes of apoptosis 
 
Since  the discovery of apoptosis, the morphological changes associated with 
apoptosis have been widely used to detect apoptotic cell death.These morphological 
changes include,membrane blebbing,shrinking of cytoplasm, condensation of 
nucleus and formation of apoptotic bodies. 
 
Although useful in later stages of apoptosis, it is not possible to detect 
apoptosis in early stages and measure the total amount of the apoptotic cells.  
 
DNA fragmentation assays 
 
DNA laddering takes place during apoptosis, because of the presence of caspase 
dependent endonucleases. Agarose gel electrophoresis is a commonly used method to 
detect the ladder pattern of DNA, but it is not possible to quantify the result.  
 
TUNEL Assay (TdT-mediated conjugated dUTP nick end-labeling) 
 
 During apoptosis, after cleavage of DNA, single strand breaks in high 
molecular weight and double stranded DNA in low molecular weight are formed. 
These fragments can be detected by TUNEL assay. This can be achieved by 
enzymatic labeling of 3’-OH ends of fragmented DNA. For incorporation of labeled 
nucleotides into DNA strand breaks, terminal deoxynucleotidyl transferase (TdT) can 
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be used. This method is known as TUNEL assay (Gavrieli et al., 1992). The 
disadvantage of this method is that late necrotic cells, showing DNA degradation, is 
also labeled. 
 
Annexin V 
 
 Annexin V is a method, which is generally used to detect apoptosis. Annexin 
V belongs to calcium- dependent phospholipid-binding protein family; therefore it 
binds phosphotidylserine (PS) in the presence of calcium ions. PS in cell membrane 
is externalized to the surface in very early stages of apoptosis by the action of 
flippases. Annexin V is used to detect PS in the outer membrane that has occurred 
after any kind of cell membrane injury. 
 
1.6 Hybridoma technology and monoclonal antibodies 
 
Monoclonal antibodies (mAb) are essential reagents that are used in several 
fields such as diagnosis of diseases, treatment of diseases such as infections and 
cancer. The first and now generally used method for producing homogeneous or 
monoclonal antibodies of known specificity was described by George Köhler and 
Cesar Milstein in 1975. This technique is based on the fact that each B lymphocyte 
produces antibody of a single specificity. Since   normal B-lymphocytes cannot grow 
indefinitely, it is necessary to immortalize B cells that produce a specific antibody. 
This is achieved by cell fusion between a normal antibody producing B cell and a 
myeloma cell, followed by selection of fused cells that secrete antibody of the desired 
specificity derived from the normal B cell. Such fusion-derived immortalized 
antibody-producing cell lines are called hybridomas, and the antibodies they produce 
are monoclonal antibodies (Abbas and Lichtman, 2003). Cell lines or clones taken 
from animals that have been immunized with the substance that is the subject of study 
produce these antibodies (Nelson et al., 2000). 
 The therapeutic potential of monoclonal antibodies (mAb) was realized after 
the hybridoma technique gave rise their development in the mid 1970s as mentioned 
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above. Since then many therapeutic strategies have been developed particularly in the 
treatment of cancer. (Breedveld, 2000). “Rituximab” was the first produced antibody 
that is directed against CD20. It is a transmembrane protein on pre- and mature B-
lymphocytes. Growth factors are also used as targets for the generation of monoclonal 
antibodies. For example, antibodies directed to epidermal-growth-factor receptors 
inhibited the growth of some tumors. Trastuzumab (Herceptin), which is a humanized 
IgG1 mAb, have been used successfully in the treatment of breast cancer (Breedveld, 
2000). 
 
1.7 Aim and Strategy 
 
This project aims to produce mAbs against proteins that are differentially 
expressed in apoptotic cells and to investigate these Abs as novel apoptotic markers. 
In our study, UV induced apoptotic HUH-7 cells were injected into mice to obtain 
mAbs. Cell ELISA assays were performed in order to  screen hybridoma clones 
reacting with apoptosis induced HUH-7 cells. The next step was to explore the 
differential expressions of antigens recognized by these monoclonal antibodies in 
apoptotic and non-apoptotic cells. For this purpose, immunofluorescence, 
immunoprecipitation, and western blotting assays were performed. 
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2.MATERIALS AND METHODS 
 
 
2.1. Production and screening of hybridomas 
 
9C11, 6D5 and other monoclonal antibodies were previously produced by 
Tamer Yağcı. One to five millions of apoptotic Huh-7 cells were injected four times 
into the peritoneal cavity of Balb/c mice at 3 weeks intervals. After the last injection 
splenic cells of immunized mice were fused with SP2/0 mouse myeloma cells by 
using polyethylene glycol (PEG), and antibody producing hybridomas  were screened  
by cell-ELISA. Positive clones were further subcloned to ensure the monoclonality 
and 6D5 and 9C11 antibodies were chosen for further characterization studies.  
 
Cell ELISA  (Enzyme-Linked Immunosorbent Assay) 
 
The Cell-ELISA assay was performed to screen the hybridomas in order to 
identify positive clones, which secrete antibodies recognizing apoptotic Huh-7 cells. 
To do this Huh-7 cells were cultured in 96 well plates in Dulbecco’s Modified 
Eagle’s Medium (DMEM) containing % 10 FCS, 1% penicillin/streptomycin and 1% 
non-essential amino acid (DMEM-10 thereafter). Plates were incubated overnight in 
CO2 incubator at 37o C and the next day wells were washed two times with PBS. 
 Cells were fixed with 125 µl. of 4% formalin / well (formalin was prepared freshly in 
PBS) for 15 minutes. After one wash with PBS, cell permeabilization was performed  
by using 125 µl.  of  0.2% Triton X-100 / well for  5 minutes (Triton X-100 was 
prepared in PBS), and then  wells were washed twice with ddH2O. 
For Blocking, 250 µl. of  2% BSA in PBS was added to the wells and incubated at 
37oC for 1 hour. After discarding the blocking solution, previously collected 
supernatants were added to the wells (50 µl.), incubated 2 hours at 37oC (Primary 
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Antibody) and washed with twice ddH2O. DMEM-10 medium was used as a negative 
control.  
 Alkaline phosphatase (AP) conjugated secondary antibody was prepared in 1% BSA- 
PBS from a stock solution (Rabbit anti-mouse AP Sigma) in 1:1000 dilution, added to 
each well and incubated at 37oC for 1 hour. Meanwhile, substrate and buffer tablets 
(Sigma Fast p-Nitrophenylphosphate Tablet sets p(NPP) Alkaline Phosphatase 
Substrate) were dissolved  in ddH2O and kept in the dark. Wells were washed 4 times 
with distilled water and previously prepared substrate mixture was added to the wells 
and left 45-60 minutes at room temperature. When color change was observed in the 
wells, plates were read at A405 in ELISA reader (Beckman Biomek 2000). 
 
 
2.2 Culture and maintenance of hybridomas. 
 
The frozen 9C11 and 6D5   antibody producing hybridoma stocks were cultured in 
high glucose DMEM supplemented with 10% fetal calf serum. FCS, 1% 
penicillin/streptomycin, 1% nonessential aminoacids and %1 L glutamine. Cells were 
grown at 37oC  and 5% CO2 and hybridoma supernatants were collected by 
centrifugation of the culture medium at 1500 rpm for 5 minutes at 4oC. This collected 
supernatants were buffered with 1 M of Tris-HCl pH. 8 to reach a final concentration 
of 20 mM Tris-HCl; Na Azide was added at a final concentration of 0.02%. Stocks of   
hybridomas were frozen in freezing medium containing 90% FCS and 10% 
dimethylsulfoxide (DMSO) and kept in liquid nitrogen tank. 
To thaw frozen cells, one vial of hybridomas was taken from nitrogen tank and 
transferred into the ice immediately. Then, vial was  placed into 37oC water bath until 
complete dissolvation. Cells then were transferred  into the centrifuge tubes and 
washed once with complete DMEM. After centrifugation at 1500 rpm at 4o C for 5 
minutes, supernatant was discarded and the resuspended pellet was poured in 10 ml of  
warm culture medium into 25 cm2 flasks. The viability of cells was checked in the 
following days. 
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Growing hybridomas were split twice a week in 1:4 to 1:5 ratio. Each time 
supernatants were collected by centrifuging the culture medium at 1500 rpm for 5 
minutes and stored at 4o C.  
 
PBS solution (10X) 
NaCl                        80 g 
KCl                           2 g 
Na2HPO42H2O       7.64 g 
KH2PO4                   2 g 
Complete to 1L with distilled water (pH:7.4). 
 
 
 
2.3.Purification of the antibodies 
 
 Protein G coated agarose beads were washed three times with PBS, each for 
15 minutes. 6D5 and 9C11 supernatants, each 100 ml, were completed to 200 ml. 
with PBS and incubated with washed beads at room temperature for 2 hours by 
rotating continuously. Supernatants were centrifuged at 2500 rpm for 2 minutes and 
the protein G pellets were washed three times with PBS. Antibodies were eluted in 
elution buffer at pH 2.6. And neutralized immediately with Tris-HCl   pH 8.8. 
Protein concentration was determined by measuring the OD values of eluates at A280. 
Eluates were also run in Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis 
(SDS-PAGE) and protein bands visualization was accomplished by coommassie 
staining. Antibody purification experiment was also performed with ascite fluids 
generated in nude mice. 9C11 and 6D5 eluates were dialyzed against PBS.  
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Elution buffer 
  
0,1 M   glycinehydrochloride, pH 2.6 
 
For 1 lt: To 900 ml deionized   water, add 7.51 g of glycine. Adjust pH to 2.6 with 5N 
hydrochloric acid. (HCI). Add deionized water to a final volume of 1000 ml. 
   
 
2.4.Subculturing of HUH-7 Cells 
 
Cells were splitted once a week   and renewal of culture medium was done 
every 3 days. For splitting, medium was aspirated   and the cells were washed twice 
with PBS. Trypsin (BIOCHROM AG) was added to the plates and plates were 
incubated in the incubator for 3-5 minutes until the cells are detached. Detached cells 
were transferred to the centrifuge tubes, centrifuged at 1500 rpm   for 5 minutes. Cell 
pellets were resuspended in fresh DMEM-10 and plated in the desired dilution into 
new plates. 
 
 
2.5.Immunoflouresence with   6D5 and 9C11 
   
Huh-7 cells were grown on sterile cover slips in 6 well plates and incubated 
overnight to   allow cells attach the cover slips. Cells were washed twice with PBS 
and fixed with ice-cold methanol for 10 minutes at –20oC. Since methanol was used, 
permeabilization step was skipped and after two wash steps with PBS, cells were 
incubated with 9C11 and 6D5 supernatants at room temperature for 1 hour. After 
washing three times with PBS, Fluoresceinisothiocyanate FITC-conjugated goat-anti-
mouse antibody (DAKO) was used as the secondary antibody and diluted at a ratio of 
1:200 in 20 mM Tris HCl pH 8. An incubation of 1 hour at room temperature in the 
dark was followed with 4 PBS washes. In each immunoflourescence experiment, cells 
were counterstained with Hoechst 33258 (Sigma). Cells were incubated for 10 
minutes in the dark, with the dye at a dilution of 1:700. Cover slips were washed with 
distilled water for 10 minutes and each cover slip was placed on a microscope slide  
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by using mounting solution. Slides were examined under fluorescent microscope 
(Zeiss). 
 
Hoechst solution 
Hoechst 33258 dye stock solution: 400 µg/ml in water 
Hoechst 33258 dye final solution: 3 µg/ml 
 
Mounting Solution: 
50% glycerol 
50% ddH2O 
 
 
2.6.Immunoperoxidase 
 
  Huh-7 cells were grown on sterile cover slips in 6 well plates and incubated 
overnight to   allow cells attach the cover slips. The next day, medium was aspirated 
and the cells were washed three times with PBS and fixed with ice-cold methanol for 
5 minutes at –20o C. After fixation methanol was aspirated, wells are washed with 
PBS and left at room temperature for the evaporation of remaining methanol. To 
prevent nonspecific binding, cover slips were blocked with PBS containing 10% FCS 
and the blocking step lasted 30 minutes at room temperature. At the end of this 
incubation, blocking solution was aspirated and wells were rinsed once with PBS. 
Then, fixed cells were incubated with primary antibody for 1 hour at room 
temperature. Wells were washed three times with PBS and each cover slip was 
covered with 2 drops of Biotinylated secondary Ab for ten minutes. After another 
washing with PBS, cover slips were treated with 2 drops of strepto avidin-horse 
radish peroxide for ten minutes and washed again with PBS. Then, DAP was 
prepared very quickly as recommended by the manufacturer, added to the each well, 
and color development was observed (1 to 5 min.). Reaction was stopped by rinsing 
the cover slips with distilled water and hematoxylene counterstaining was performed 
for the visualization of nuclei. To get rid of hematoxylene background, cover slips 
were washed thoroughly with distilled water. Finally, each cover slip was mounted 
onto glass slides by using mounting solution. 
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2.7.Protein extraction from cells (preparing cell lysates) 
 
When cells grown to 70-80% confluency, they were washed twice with ice 
cold PBS, scraped in a small volume of the same buffer and centrifuged at 1500 rpm 
for 5 minutes at 4oC. Pellets were either kept at –80oC or lysed immediately in NP-40 
lyses buffer. 
NP-40 lyses buffer:  150 mM NaCl 
1% NP-40 (Igepal-Sigma)  
50mM Tris (pH 8.0) 
For lysis, the pellets were resuspended in 4 to 5 volume of NP-40 lyses buffer 
supplemented with protease inhibitors (Roche; EDTA free complete protease 
inhibitor cocktail) and incubated on ice for 30 minutes. The lysates were centrifuged 
at 13000 rpm for 30 minutes at 4oC. Supernatants were transferred into fresh tubes 
and following protein quantitation; proteins were aliquoted and stored at –80oC. 
   
Bradford Stock solution 
Ethanol (95%)                            4,75 ml 
dH2O                                          250 µl 
Phosphoric acid (85%)              10   ml 
Coomassie Brilliant Blue          17,5 mg 
 
Bradford Working solution 
dH2O                              21.25 ml 
Ethanol (95%)                  0,75 ml 
Phosphoric acid (85%)      1,5 ml 
Bradford stock solution     1,5 ml 
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Bradford Assay for Protein Quantitation 
 
A standard curve was prepared by using BSA as described below: 
Tubes    1 2 3 4 5 6 7 8 
BSA(µl)  0 2.5  5 7.5 10 12.5 15 20 
dH2O(µl)  100 97.5 95 92.5 90 87.5 85 80 
Bradford working  
solution(µl)   900  900 900 900 900 900 900 900 
 
 
   
   
 Protein samples were prepared as described below: 
 
Tubes   1 2 3 4 5 
Samples  0 2 2 2 2 
dH2O  (µl)  98 98 98 98 98 
Bradford   (µl)  900    900      900     900       900     
Lysis buffer  (µl)         2           -           -          -          - 
 
A595   values were measured immediately (5-30 min.). 
 
2.8.Western Blotting 
 
SDS-Polyacrylamide gel electrophoresis of proteins 
 
For resolving gel 
The glass plates were casted according to the user guide instructions. SDS-PAGE gels 
with different acrylamide concentrations were prepared considering the linear range 
of separation (kD). Acrylamide solution was prepared quickly, poured into the space 
between the glass plates and overlayed with a thin layer of iso-buthanol. After 
polimerization was complete, iso-buthanol was removed and the surface of the gel 
was washed several times with deionized water. Any remaining water was discarded 
by using the edge of a paper towel. 
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For stacking gel 
This was prepared in a disposable plastic tube at an appropriate volume and desired 
concentration. Then, the stacking gel solution was poured onto the surface of the 
resolving gel. The comb was immediatelly inserted into the stacking gel avoiding air 
bubble formation. The gel was placed in a vertical position at room temperature. 
While the gel was polimerizing, samples to be loaded were prepared by boiling them  
in 1X SDS gel-loading buffer at 100o C for 5 minutes to denature the proteins. After 
the polimerization of the stacking gel was complete, the comb was removed carefully 
and each well was checked to discard any unpolymerized acrylamide. The gel was 
placed in the electrophoresis apparatus and electrophoresis running buffer was poured  
into top and bottom reservoirs. Any bubble were removed  carefully  by using a 
syringe and  5-100 µg of protein was loaded into the wells. 
The electrophoresis apparatus was attached to the power supply and the gel was run at 
a constant volt (80) until the dye has passed to the resolving gel. Then, as the dye 
reached the resolving gel, voltage was increased to 120-150 volt. When the dye 
reached the bottom of the  gel, power supply was turned off and the glass plates were 
removed from the apparatus. Plates were separated by using a spatula and the gel was 
transferred into transfer buffer. 
 
 
  Reagents  for SDS –PAGE gel preparation 
 
  Stock solutions 
 
 
Acrylamide/bisacrylamide 
        Acrylamide      (29.2 g /100 ml)                                146  g 
        N’N’-Bis-methylene-acrylamide (0,8 g/100 ml)          4 g 
        Made to  500 ml with distilled  water. Filtered and stored at 4o C in the dark (30 
days max) 
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1.5 M Tris-HCl    pH:8.8 
Tris-Base (18.15 g/100 ml)                     54.45 g 
Distilled water                                         150  ml 
Adjusted to  pH:8.8 with 1N HCl;  made to 300 ml with distilled water and stored at 
4oC. 
 
 
0.5M Tris-HCl  pH:6.8 
Tris-Base              6 g 
Distilled water    60 ml 
Adjusted to pH: 6.8  with  1N HCl. Made to  100 ml with distilled water and stored at 
4o C. 
 
 
10% SDS 
10 g SDS was dissolved  in water with gentle stirring and completed to 100 ml with 
distilled water. 
 
 
Sample Buffer (SDS reducing  buffer )-5X 
( Stored at room temperature) 
 
0.225M     Tris     pH:6.8 
50%             Glycerol 
5%               SDS 
0.05%          BPB(Bromophenol Blue) -add freshly 
0.25M         DTT (reducing) 
Completed to 40 ml. 
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Electrophoresis buffer (Running Buffer)  -5X 
 
Tris- Base         45  g 
Glycine         216   g 
 
SDS                15   g 
Completed to 3 lt with distilled water. 
Store at  4oC. 
Diluted to 1X before using;  pH adjustment with acid or base  not required. 
 
 
Components for  preparing 10% resolving gel 
 
10% Gel   5 ml  10 ml   15 ml  20 ml  25 ml 
dH2O 1.9 4 5.9 7.9 9.9 
30% mix 1.7 3.3 5 6.7 8.3 
1.5 M Tris 
(pH 8.8) 
1.3 2.5 3.8 5 6.3 
10% SDS 0.05 0.1 0.15 0.2 0.25 
10% APS 0.05 0.1 0.15 0.2 0.25 
TEMED 0.002 0.004 0.006 0.008 0.01 
 
 
 
Components for  preparing 5% stacking gel 
 
5%  Gel   1 ml  2  ml   3 ml  4 ml  5 ml 
dH2O 0.68 1.4 2.1 2.7 3.4 
30% mix 0.17 0.33 0.5 0.67 0.83 
1.5 M Tris 
(pH 6.8) 
0.13 0.25 0.38 0.5 0.63 
10% SDS 0.01 0.02 0.03 0.04 0.05 
10% APS 0.01 0.02 0.03 0.04 0.05 
TEMED 0.001 0.002 0.003 0.004 0.005 
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Transfer of  proteins from SDS-polyacrylamide gels to solid supports 
 
After the running process was complete, four pieces of Whatman 3MM paper  
and one piece of transfer membrane (PVDF or nitrocellulose)  were cut to the exact 
size  of the SDS-polyacrylamide gel by wearing gloves. The membrane was left in 
methanol for a few seconds, washed with deionized water and soaked into the transfer 
buffer for 15 minutes along with Whatman  3MM papers.  
 
 
Preparing of transfer sandwich 
 
2 wet pieces of Whatman 3MM paper  were placed onto the anode plate of the 
transfer apparatus (Bio-Rad, trans-blot) onto which, the membrane was layered. Then, 
the gel  was transferred  on this layer  of papers and protein markers were punched by 
using  a needle to replicate them on the membrane. Meanwhile, the corner of the 
memrane was cut to fix its orientation and the transfer sandwich was completed by 
putting the other 2 wet pieces of Whatmann 3MM paper. The transfer apparatus was 
assembled by placing the upper plate (cathode) on the top of transfer sandwich.. 
The transfer system was connected to the power supply and the transfer was done at 
constant current of 3.5 mA/cm2 of the gel for a period of 45 minutes. Electrical 
current was turned off and the membrane was removed from the apparatus. 
 
 
Transfer Buffer 
 
Glycine             2.9 g 
Trisma –Base    5.8  g 
SDS                 0.37  g 
Methanol          200  ml 
Adjust volume to 1lt with ddH2O 
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Immunological detection of immobilized proteins (Western Blotting) 
 
After the transfer process was completed, the membrane was immersed in the 
blocking solution for one hour to prevent non-specific binding. After washing, 
supernatants of 6D5 and  9C11 were added and the membrane was incubated with 
these primary antibodies at room temperaure for one hour or at 4o C O/N on a rotating 
platform. Then the antibodies were removed by three washes of TBS-T, one for 15 
minutes and two for 5 minutes. Following the washes, the membrane was incubated 
with 5000 times diluted secondary antibody (HRP-conjugated rabbit anti-mouse Ig-
DAKO) for 1 hour  at rooom temperature. After the final washing step, the membrane 
was treated with chemiluminescent substrate to visualize transferred proteins. 
 
Blocking solution 
5% milk powder in 0.1%Tween-TBS solution. 
 
(Secondary antibody was diluted in blocking solution containing 3% milk powder.) 
 
 
Detection of proteins immobilized on the membrane 
 
Detection of the protein was done with ECL Plus Western Blotting Kit 
(Amersham Life Science; Catalog no: RPN 2106). Membrane was taken away from 
the TBS-T and touching the edge of the membrane to Whatmann 3 MM paper drained 
excess buffer. ECL Plus, which was prepared according to the manufacturer 
instruction, was dropped onto the membrane and after 5 minutes films were 
developed in the dark room by using Automated Developer Machine (Amersham 
Hyper processor). 
 
 
Equal loading 
 
Both anti-Calnexin (AF-18) and cytokeratin-18 monoclonal antibodies were 
used for this purpose. Developed membrane was incubated with blocking solution 
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and blot processing with either of these antibodies was accomplished as mentioned 
above (Detection of proteins immobilized on the membrane). 
 
 
2.9.Immunoprecipitation (IP) with 9C11 and 6D5 
 
Huh-7 cells grown to 70-80% confluency were scraped with ice-cold PBS and 
stored at –80oC for protein extraction or immediately lysed in lysis buffer. (150mM 
Na CI,1% NP-40, 50mM Tris pH8, protease inhibitor cocktail-Roche). Meanwhile, 
the Protein G Gel Slurry (East Coast Biology / R801- H2261) was washed with lysis  
buffer three times, each for 15 minutes. To avoid non-specific antibody binding, 
extracted proteins and Protein G beads  were co-incubated in microcentrifuge tubes, 
for 2 hours at room temperature or overnight at 4oC (preclearence). After 
preclearence, tubes were centrifuged at 2500 rpm for 2 minutes and the supernatants 
were transferred into fresh tubes. 100 µl. of primary antibody was added and tubes 
were incubated for 2 hours at room temperature by rotating them constantly. Then, 
Protein G was added to obtain the triple complex (Antibody+Antigen+Protein G) and 
tubes were incubated O/N at 4oC. The next day, tubes were centrifuged at 2500 rpm 
for 2 minutes and supernatants were discarded. Pellets were washed three times with 
lysis buffer without NP-40 and resuspended in 2X loading buffer. 
Immunoprecipitated proteins were run in 10% SDS-PAGE and protein transfer and 
detection were accomplished as described above.  
 
 
2.10.Induction of apoptosis by UV-C 
 
HUH-7 cells were treated with UV-C to induce apoptosis (125mJ/cm2). For this 
purpose, culture medium was aspirated; cells were washed twice with PBS and 
exposed to UV irradiation in Petri dishes by using Stratagene UV-Linker Apparatus. 
Before placing cell culture dishes into the apparatus, washing medium was aspirated 
and lids of dishes were displaced.  Then, fresh medium was added and culture plates 
were transferred into the CO2 incubator. Apoptotic cells were observed under inverted 
light microscope (Zeiss) 
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2.11.Induction of apoptosis by activation of death-receptor mediated apoptosis 
 
Jurkat cells derived from a human T-cell leukemia were cultured to subconfluency in 
RPMI medium up to 106 cells / ml. Anti-Fas antibody (Upstate Biotechnology-clone 
CH11) was added to culture flasks at a concentration of 25-50 ng/ml. Cells were 
collected after 16 hours and pelleted for protein extraction. 
 
 
2.12.Induction of apoptosis by serum starvation 
 
Hepatocellular carcinoma cells were grown under serum free conditions for three 
days in order to induce apoptosis. By the end of this period, as the cells started to 
show morphological characteristics of apoptosis, cells were scraped as previously 
described and cell pellets were stored at -80oC for protein extraction. 
 
 
2.13.Induction of apoptosis by oxidative stress  
 
It was performed in two ways. 
i) Huh-7 cells were incubated in a culture medium containing 0.1% FCS for 72 hrs, 
and then treated with freshly prepared 100 µM H2O2. Cells were collected after 
minimum 4 hrs (Sayan et al ., 2001). 
ii) Cells were directly treated with 500µM H2O2 . 
 
Annexin V assay 
 
Cells were grown on sterile cover slips   treated with Annexin -V-Fluos (Roche 
Annexin-V-FLUOS staining Kit) for 10 minutes as recommended by manufacturer. 
Then, cells were observed under fluorescence microscope (Zeiss). 
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2.14.Kinetic assays 
 
After UV-induction,  Huh-7 cells were  harvested at different periods. At 0; 2; 4; 8; 16 
and 24. hour, cell pellets were collected and western blotting and staining 
experiments were performed. 
 
After Serum starvation, cell pellets were taken at 0; 1; 2; 3; 4; 5th day and western 
blotting and staining experiments were performed. 
 
   After 500 µM H2O2 treatment, cell pellets were collected at 0; 1; 2; 4; 8; 16; 24th hours 
and western blotting and staining experiments were performed. 
 
   After100µM H2O2 treatment, pellets were taken at 0; 2; 4; 8; 16; 24th hours and then 
western blotting and staining experiments were performed. 
 
 
 
31 
 
 
 
 
3. RESULTS 
 
Results are explained in the following order: 
 
*Production of monoclonal antibodies. 
*Comparison of Hybridoma clones. 
*Biochemical characterization of the antigens recognized by 6D5 and 9C11. 
       Western Blotting with 9C11 and 6D5 
        Immunoprecipitation with 9C11 and 6D5. 
*Expression of 9C11 and 6D5 in apoptotic cells. 
*Immunofluorescence with 9C11 and 6D5. 
*Immunoperoxidase with 9C11 and 6D5. 
 
 
 
3.1. Production of monoclonal antibodies. 
 
 
Balb/C mice were immunized with apoptotic Huh7 cells. Animals were 
sacrified and splenic cells were fused with SP2/0 parental myeloma cells. Initially 
antibody-secreting cells were screened by Cell-ELISA, western blot and 
immunoprecipitation experiments, and 2 clones, namely 6D5 and 9C11 out of 4 
were selected for further characterization studies (Figure 5 and 6). We also 
demonstrated that 6D5 and 9C11 antibodies recognize different proteins. 
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Figure 5. Antibody presence in the supernatants of four  hybridomas were 
shown, as evidenced by immunoprecipitating supernatants directly with protein G 
beads and subjecting immunoprecipitates to SDS-PAGE and western blot. 50 kd 
bands correspond to the heavy chain of antibodies.  
 
  3.2. Comparison assay for 11G8, 6D5, 6E10 and 9C11 
          
a 
 
 
 
 
  
    
 
 
 
 
b 
 
 
 
 
 
  
 
 
 
Figure 6. Immunoprecipitated HUH7 cell lysates with 9C11, 6D5, 6E10 and 
11G8 antibodies and  immunoprecipitates were loaded  to SDS-PAGE as three 
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identical sets, except the 11G8 one. After their transfer onto PVDF membrane, each 
set was probed with 6E10, 6D5, 9C11 and 11G8, respectively (6a). Then, 
membranes of 9C11 and 6E10 were probed with 11G8 (6b). 6E10, 6D5 and 11G8 
antibodies  (6a-i; 6a-ii; 6b-iii and 6b-i respectively) were shown to  recognize the 
same antigen, except 9C11, which recognized a different one. Upper bands 
correspond to proteins recognized by our antibodies (approximately 75 kD), and 
lower bands indicate the heavy chain of immunoglobulins. 
 
 
3.3.Biochemical characterization 
 
        Western Blotting with 9C11 and 6D5 monoclonal antibodies 
 
We also investigated the differential expression of proteins recognized by our 
antibodies, in the context of apoptosis. Total cell lysates from apoptotic and non-
apoptotic Huh7 and Jurkat cells  were prepared and loaded to 10% SDS-PAGE. 
After their transfer to PVDF membranes, proteins were probed with 6D5 and 9C11 
antibodies. Negative controls, which were not treated with primary antibodies,  were 
also included (not shown). As shown in figure 7., 9C11 antibody recognized both 
apoptotic and non-apoptotic Huh7 and Jurkat cells (Figure 7. lanes 1, 2, 3 and 4). 
However, 6D5 antibody failed to react with any protein of Jurkat cells (Figure 7. 
lanes 5, 6) while recognizing apoptotic and non-apoptotic HUH7 cell lysate (lane 7 
and 8 of the same figure). These results clearly demonstrate that 6D5 antibody has a 
more restricted tissue recognition pattern. 
 
  
 
 
              9C11             6D5 
 
 Figure 7. Western Blotting with 9C11 and 6D5 monoclonal antibodies 
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Lane 1: Jurkat; Lane 2: Jurkat+Anti-Fas Antibody; Lane 3: Huh7; Lane 4: Apoptotic 
Huh7 (Lane 5-6-7-8: same order). 
Huh7 cells were exposed to UV-C (20 J/m2) in order to induce apoptosis. Jurkat 
cells were treated with anti-Fas antibody (50 ng /ml) for apoptosis induction. Non-
apoptotic and apoptotic cell proteins from both cell lines were probed with 9C11 
(lanes 1, 2, 3 and 4)  and 6D5 (Lanes 5, 6, 7, 8) in western blotting assay. There was 
no differential protein expression between non-apoptotic and apoptotic cells.  
 
 
We also performed western blot experiments to show the binding strength of our 
antibodies to their cognate ligands. To do this, total cell lysates of HUH7 cells were 
loaded on SDS-PAGE at different concentrations varying from 1µg. to 20 µg. Even 
the lowest concentration of proteins reacted with 9C11 (figure 8a) and 6D5 (figure 
9a). Apoptotic cells show less band intensity than non-apoptotic cells (Lanes 2, 4, 6, 
8 in figure 8a and 9a). 
 
 
 
a. 
 
 
 
 
 
 
     
 
 
  b. 
        
 
 
 
 
                   
 
Figure 8. Different protein concentrations with 9C11. Lysates that had been 
obtained from both apoptotic and non-apoptotic Huh7   cells were run in 10% SDS-
PAGE at concentrations indicated below and transferred to PVDF membrane. 
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Lane 1: non-apoptotic -1µg, Lane 2: apoptotic -1 µg, Lane 3: non-apoptotic-5 µg, 
Lane 4: Apoptotic -5 µg, Lane 5: non-apoptotic -10 µg, Lane 6: Apoptotic-10 µg, 
Lane 7: non-apoptotic - 20 µg, Lane 8: Apoptotic-20 µg, Lane 9: negative control 
(not probed with 9C11).  Membrane was probed with 9C11 to show the antibody 
strength (a) and with anti-CK-18 mAb to check the protein amounts that were 
loaded (b).  
 
 
 
               a. 
 
 
 
 
 
 
              b. 
          
                
 
 
 
 
Figure 9. Different protein concentrations with 6D5. Lysates that had been 
obtained from both apoptotic and non-apoptotic Huh7   cells were run in 10% SDS-
PAGE at concentrations indicated below and transferred to PVDF membrane. 
Lane 1: non-apoptotic -1µg, Lane 2: apoptotic -1 µg, Lane 3: non-apoptotic-5 µg, 
Lane 4: Apoptotic -5 µg, Lane 5: non-apoptotic -10 µg, Lane 6: Apoptotic-10 µg, 
Lane 7: non-apoptotic - 20 µg, Lane 8: Apoptotic-20 µg, Lane 9: negative control 
(not probed with 6D5).  Membrane was probed with 6D5 to show the antibody 
strength (a) and with anti-CK-18 mAb to check the protein amounts that were 
loaded (b). 
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3.4 Kinetic Assays in different apoptosis induction methods 
 
3.4.1 UV induction 
 
HUH7 cells were exposed to UV-C irradiation to induce apoptosis and cell lysates 
were collected at different time course. As shown in figure 10, there was a 
significant signal reduction in early apoptotic stage (2, 4 and 8th hours.), but the 
protein expression was recovered in 16th and 24th hours. The differential expression 
was more obvious in equal loading membrane (figure 10b lower bands), since the 
bands in the membrane probed with 9C11  were at saturation (figure 10a). 
 
   
 
a. 
 
        
 
 
 
 
 
 
b. 
 
 
           
 
                    
 
Figure 10. Kinetic assay in UV-induced apoptosis. 
Huh7 cells were treated with UV-C and cells were harvested at different periods. 
Lane 1: No UV induction, Lane 2-6: 2, 4, 8, 16, 24 hrs respectively after UV 
induction . Total lysates of these cells were run in SDS-PAGE and proteins were 
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probed with 9C11 after their transfer onto PVDF membrane (a). Equal loading was 
performed with AF-18, anti-calnexin monoclonal antibody (b). The same pattern was 
also observed in the experiment performed with 6D5 but, several bands appeared in 
the membrane probed with this antibody (figure 11a). These results lead us to 
speculate that the protein recognized by 6D5 antibody might have different isoforms 
or distinct proteins sharing a common epitope were visualized in our western blots. 
 
 
 
 
             a. 
 
 
 
 
 
 
      
                                                
 
 
 
                b.                                 
 
 
 
 
 
 
 
 
 
  
 
 
Figure 11.  Kinetic assay in UV-induced apoptosis. 
Huh7 cells were treated with UV-C and cells were harvested at different periods. 
Lane 1: No UV induction, Lane 2-6: 2, 4, 8, 16, 24 hrs, respectively after UV 
induction . Total lysates of these cells were run in SDS-PAGE and proteins were 
probed with 6D5 after their transfer onto PVDF membrane (a). Equal loading was 
performed with AF-18, anti-calnexin monoclonal antibody (b, upper bands). 
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            Annexin V Assay 
One of the most common techniques used is the detection of phosphotidylserine in 
the outer leaflet of the plasma membrane of apoptotic cells, using labelled annexin V. 
Therefore, we confirmed the occurrence of apoptosis after treatment of Huh7 cells 
with UV-C irradiation by using Annexin V assay (figure 12).  
 
 
                                                                                                    
  
 
 
 
 
 
  
 Figure 12. Annexin V Assay.  Apoptosis was induced by UV-C irradiation ( 20 
J/m2 ) and cells were subjected to Annexin V assay at 4th and 24th hour after 
treatment (A and C, respectively). Untreated cells were used as negative controls for 
indicated times (B and D, respectively). 
 
 
 
3.4.2. Starvation  
 
 
Huh7 cells were grown in serum free conditions to induce apoptosis and cell 
lysates were collected at different time course. Control cells grown in DMEM-10 and 
DMEM-0 supported with 100 nM selenium were also included in the experiment, 
since such growth conditions do not allow apoptosis to occur. The follow-up of 
apoptosis development was performed by morphological analysis of starved cells 
under inverted microscope (data not shown). Total lysates of these cells were run in 
SDS-PAGE and proteins were probed with 9C11 (figure 13) and 6D5  (figure 14a) 
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after their transfer onto PVDF membrane. Equal loading was performed with AF-18, 
anti-calnexin monoclonal antibody (figure 13b and figure 14b) .  
Under starvation condition, HUH7 cells have been reported to undergo apoptosis 
starting from day 3, and increase in the following days (Sayan et al, 2002.). In our 
starvation assay, we observed, as in UV-induced apoptosis experiment, that proteins 
recognized by 9C11 and 6D5 antibodies were down-regulated in the early phases of 
apoptosis (day 3; figure 13-lane 5 and figure 14a-lane 5). However, the band 
intensity of proteins were recovered in day 4 and 5 (figure 13 and 14a, lanes 6 and 7). 
This result was also consistent with our previous observation in UV-induced 
apoptosis assay, in which the same recovery was encountered in the late phase of 
apoptosis (figures 6a, 6b, 7a and 7b; lanes 5 and 6). 
     
 
  
 
 
              
 
 
 
 
Figure 13. Kinetic assay in starvation with 9C11 
Cells were grown in serum free conditions to induce apoptosis. Total lysates of these 
cells were run in SDS-PAGE and transferred onto PVDF membrane. Proteins were 
probed 9C11 (lower bands) and  AF-18 (upper bands), anti-calnexin monoclonal  
antibodies. 
Lane 1: Control 1 (DMEM-10), Lane 2: control 2 (DMEM-0 containing 100 nM 
selenium), Lane 3-7: day 1, day 2, day 3, day 4 and day 5, respectively after 
starvation. 
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Figure 14. Kinetic assay in starvation with 6D5 
Cells were grown in serum free conditions to induce apoptosis. Total lysates of these 
cells were run in SDS-PAGE and transferred onto PVDF membrane. Proteins were 
probed with 6D5 (a) and  AF-18 (b), anti-calnexin monoclonal  antibodies. 
Lane 1: Control 1 (DMEM-10), Lane 2: control 2 (DMEM-0 containing 100 nM 
selenium), Lane 3-7: day 1, day 2, day 3, day 4 and day 5, respectively after 
starvation. 
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3.4.3. H2O2   treatment 
 
The fact that cells undergo apoptosis with reactive oxygen species (ROS) and direct 
treatment of H2O2 has been well established. In this context, we treated Huh7 cells 
with 500 µM H2O2    and collected cells at different times after treatment. However, 
we did not observe any morphological changes indicating apoptosis induction under 
this experimental condition (data not shown). Lysates were prepared and proteins 
were run in 10% SDS-PAGE. After transfer of proteins, PVDF membranes were 
probed with 9C11 (figure 15) and 6D5 (figure 16a). Unlike UV-induced and 
starvation-induced apoptosis, H2O2 treatment caused a gradual decrease in the band 
intensity of proteins recognized by 6D5 (figure 16a), without any recovery event in 
the late phases of apoptosis. On the other hand, we could not make such a conclusion 
in the case of 9C11 antibody, because of equal loading problem (Figure 15), yet 
decreased expression of proteins in the late phases of treatment was observed (Figure 
15 lanes 6 and 7).  
 
 
 
 
 
 
 
Figure 15.  Kinetic assay in oxidative stress with 9C11. 
Lane 1: Control (no H2O2    treatment), Lane 2-7: 1 hour, 2 hours, 4 hours, 8 hours, 16 
hours, and 24 hours, respectively after H2O2    treatment. Lane 8: negative control 
(lysate from untreated cell loaded but not probed with primary antibody). Membrane 
probed at a time with 9C11 (lower bands), and AF-18 (upper bands). 
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Figure 16. Kinetic assay in oxidative stress with 6D5 
Lane 1: Control (no H2O2    treatment), Lane 2-7: 1 hour, 2 hours, 4 hours, 8 hours, 16 
hours, and 24 hours, respectively after H2O2    treatment. Membrane was probed with 
6D5 (a) and equal loading was performed with CK18 mAb (b). 
 
 
3.4.4. Starvation and  H2O2 treatment 
 
A more intensive oxidative stress condition was also established. To do this, 
Huh7 cells were grown in 0.1% FCS for 72 hours and then treated with 100 µM 
H2O2 . Apoptotic cells were observed under light microscope even before the 
addition of H2O2 into the culture (data not shown). Cells were collected at different 
times and lysates were prepared.  Proteins were run in 10% SDS-PAGE transferred 
to PVDF membrane. This time, starvation alone caused a decrease in the expression 
of proteins recognized by both 9C11 and 6D5 (lane 2 of figure 17a and 18a, 
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respectively) and expression was recovered in the very late phase of oxidative stress 
conditions (Lane 7 of figure 17a and 18a, respectively). While evaluating these 
results, one should consider that proteins were overloaded in lanes 3 and 4 of figures 
17a and 18a. 
 
               a. 
 
 
 
               b. 
                             
                              
         
     
Figure 17. Kinetic assay in starvation and oxidative stress with 9C11. Lane 1: 
Control (DMEM-10), Lane 2: (DMEM-0.1 without H2O2 treatment), Lane 3-7: 2, 4, 
8, 16, 24 hours after treatment. Membrane was probed with 9C11 (a) and  equal 
loading was performed with AF-18 (b). 
 
a. 
 
 
 
 
 
 
 
                    
b. 
   
 
 
 
 
 
Figure 18. Kinetic assay in starvation and oxidative stress with 6D5. Lane 1: 
Control (DMEM-10), Lane 2: (DMEM-0.1, without H2O2 treatment), Lane 3-7: 2, 4, 
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8, 16, 24 hours after treatment. Membrane was probed with 9C11 (a) and  equal 
loading was performed with with CK-18 (b). 
 
 
3.5 Immunofluorescense and Immunoperoxidase with 9C11 and 6D5  
 
We continued our experiments with immunofluorescense and immunoperoxidase 
staining assays to verify western blot data. These studies allowed us to detect cellular 
localization of proteins recognized by 9C11 and 6D5, as well as the intensities of 
antibody reactivities depending on different apoptosis induction assays. Cells were 
grown on the sterile cover slips and fixed with ice-cold methanol. After their 
treatment with either antibody, fixed cells were treated with FITC or peroxidase 
conjugated secondary antibody and counterstaining was accomplished by Hoechst 
33258 or hematoxylene for immunofluorescense and immunoperoxidase, 
respectively. 
 
 
3.5.1 Kinetic assay in UV-induced apoptosis 
 
Apoptosis was induced as previously described (3.4.1.). Cover slips were collected at 
times indicated (Figure 19, 20) and cells were subjected to immunofluorescence 
assay. Concordant with our western blot experiment (Figure 10, 11), a decrease in 
the signal intensity during early phase of apoptosis was observed (C, E), and the 
expression of protein was recovered at the late phase (I, K). Non-apoptotic cells were 
included as positive control (A) and displayed strong staining pattern. 
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Figure 19. Immunofluorescence with 9C11 in UV induction. A-C-E-G-I-K, 
nonapoptotic; 2, 4, 8, 16 and 24 hrs after treatment, respectively; B-D-F-H-J-L, 
counterstaining with Hoechst 33258. Primary antibody: 9C11. Cells not treated with 
primary antibody were used as negative controls (not shown). 
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Figure 20. Immunofluorescence with 6D5 in UV induction. A-C-E-G-I-K: 
nonapoptotic, 2, 4, 8, 16 and 24 hrs after treatment, respectively; B-D-F-H-J-L: 
counterstaining with Hoechst 33258. Primary antibody: 6D5. Cells not treated with 
primary antibody were used as negative controls (not shown) 
 
                                     
3.5.2. Kinetic assay in starvation 
 
Immunofluorescence was performed after cells were grown under serum-free 
conditions. Signal decrease at day 3 and recovery of the signal intensity at days 4 and 
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5 of starvation, justified the western blot data (Figure 21 I, K, M; Figure 22 I, K, M). 
Unstarved cells were used as positive controls (Figure 21 A; Figure 22 A).  It has 
been shown that  serum-free medium containing 100 nM selenium protect cells to 
undergo apoptosis in starvation conditions, however we observed a slight decrease in 
signal intensity in cells supplied with selenium (Figure 21 C; Figure 22 C). 
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Figure 21. Immunofluorescence with 9C11 in starvation. A-C-E-G-I-K-M: 
DMEM10, DMEM0+Selenium, 1, 2, 3, 4 and 5 days after treatment, respectively; B-
D-F-H-J-L-N: counterstaining with Hoechst 33258, respectively. Primary antibody: 
9C11. Cells not treated with primary antibody were used as negative controls (not 
shown). White arrow indicates apoptotic cells. 
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Figure 22. Immunofluorescence with 6D5 in starvation. A-C-E-G-I-K-M: 
DMEM10, DMEM0+Selenium, 1, 2, 3, 4 and 5 days after treatment, respectively; B-
D-F-H-J-L-N: counterstaining with Hoechst 33258, respectively. Primary antibody: 
6D5. Cells not treated with primary antibody were used as negative controls (not 
shown). White arrow indicates apoptotic cells. 
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3.5.3 Kinetic assay in oxidative stress. 
 
 
As previously explained in (3.4.3), oxidative stress condition was generated by 
treating cells with 500 µM H2O2 and cells were collected at indicated times. After 
their incubation with 9C11 and 6D5 antibodies,  immunoperoxidase staining was 
performed (Figure 23; Figure 24). Unlike UV induction and starvation conditions, a 
gradual decrease in the staining intensity was observed with either antibody (Figure 
23. A, B, C, D, E, F, G;  Figure 24. A, B, C, D, E, F, G). 
 
    
 
  
   
 
 
                     
 
 
 
Figure 23. Immunoperoxidase assay in oxidative stress with 9C11. Cells were 
treated with 500 µM  H2O2. A-B-C-D-E-F-G: Cells grown in DMEM-10 only; and 
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cells collected after 1, 2, 4, 8, 16 and 24 hrs of treatment, respectively. 
Counterstaining was performed with hematoxylene.  Cells not treated with primary 
antibody were used as negative control H. Primary antibody was 9C11. 
 
 
     
 
 
   
 
  
  
 
 
Figure 24. Immunoperoxidase assay in oxidative stress with 6D5. Cells were 
treated with 500 µM  H2O2. A-B-C-D-E-F-G: Cells grown in DMEM-10 only; and 
cells collected after 1, 2, 4, 8, 16 and 24 hrs of treatment, respectively. 
Counterstaining was performed with hematoxylene  Primary antibody was 6D5. 
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3.5.4. Kinetic assay in starvation and oxidative stress. 
 
 
We established a more rigorous oxidative stress condition as described in (3.4.4) and 
performed immunoperoxidase staining. When treated with 9C11 monoclonal 
antibody, protein down-regulation was observed; verifying previously accomplished 
western blot experiment (Figure 25 B, C). Starting from 8 hrs after treatment of 
starved cells with 100 µM H2O2, protein expression was recovered (Figure 25 D, E, 
F). Untreated cells grown in DMEM-0.1 (starvation condition) were used as positive 
controls (Figure 25 A; Figure 26A). However in our assay with 6D5 antibody, we 
could not reproduce our western blot data, yet a decrease in staining intensity was 
evident at 16 hrs after treatment (Figure 26E) Without any recovery thereafter. 
 
 
   
 
 
   
 
Figure 25. Immunoperoxidase assay in starvation and oxidative stress with 
9C11. Huh7 cells were grown in DMEM-0.1 for 72 hours and then treated with 100 
µM H2O2.  A-B-C-D-E-G-F: Cells grown in DMEM-0.1 only; and cells collected 
after 2, 4, 8, 16 and 24 hrs of treatment, respectively. 9C11 was used as primary 
antibody.  Cells not treated with primary antibody were used as negative controls 
(not shown). 
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Figure 26. Immunoperoxidase assay in starvation and oxidative stress with 6D5. 
Cells were grown in DMEM-0.1 for 72 hours and then treated with 100 µM H2O2.  
A-B-C-D-E-G-F: Cells grown in DMEM-0.1 only; and cells collected after 2, 4, 8, 
16 and 24 hrs of treatment, respectively. 6D5 was used as primary antibody.  Cells 
not treated with primary antibody were used as negative controls (not shown). 
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                 4. DISCUSSION  
. 
Since their discovery in 1975, thousands of monoclonal antibodies have 
been used in several fields of biology such as basic research, and diagnosis, 
monitoring and treatment of many diseases. Several hundreds of proteins have been 
characterized in research laboratories by using these powerful tools. Monoclonal Abs 
have become key components in a vast array of clinical laboratory diagnostic tests. 
In diagnostic approaches, their wide application in detecting and identifying cell 
markers and pathogenic agents has largely arisen. In recent years, about ten 
monoclonal antibodies have been approved by US Food and Drug Administration 
(FDA) and launched on the market to be used for the treatment of cancer and 
degenerative diseases.  
One recent report emerged from our department and describing a 
monoclonal antibody namely NAPO (Sayan et al., 2001), clearly identified the 
disappearance of a nuclear protein in apoptotic cells and encouraged us to develop 
new monoclonal antibodies that may recognize proteins differentially expressed in 
apoptosis. To do this, mice were immunized with apoptotic Huh7 hepatocellular 
carcinoma cells and four clones strongly reacting with these cells were obtained. The 
reason for choosing this cell line was that detachment of apoptotic cells from the 
surface of culture plates is a major problem in experimental research, and that Huh7 
cells remain tightly adhered even when strong apoptosis inducing stimuli were 
applied.  
Among the two monoclonal antibodies out of four, which were studied in 
these MSc thesis work in the context of apoptosis, 9C11 recognizes a protein of  
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approximately 75 kDa in Huh-7 cells, whereas  protein reacting with 6D5 has distinct 
isomers most probably due to alternative splicing or truncation events. In our 
experiments (Figure 2), it was shown that 11G8, 6D5 and 6E10 recognize the same 
protein, but whether they bind to same epitope or not is not clear since we did not 
accomplished fine epitope mapping of these antibodies. However, 9C11 and 6D5 
differ from each other, being reacted with distinct ligands. Amino acid sequencing of 
proteins recognized by 9C11 and 6D5 antibodies could not be done so far, since such 
procedure requires a large amount of protein to be transferred onto PVDF membrane; 
yet we performed some preliminary experiments for optimizing the experimental 
conditions.  
Immunoprecipitation experiments showed that 9C11 recognizes its antigen 
both in apoptotic and non-apoptotic Huh7 and Jurkat cells, whilst the reaction of  
6D5 was restricted to Huh-7 cells in both experimental conditions (Figure 3). This 
result confirmed clearly our observation  that 6D5 and 9C11 differ in their target 
ligands and that 6D5 has more restricted tissue specificity. Since we detected strong 
band intensity during all western blot experiments, we concluded that antigens 
recognized by both antibodies are expressed abundantly in Huh-7 cells. Moreover, 
the immunoreactivity of 9C11 and 6D5 with their ligands was strong enough to 
distinguish their antigens even at low concentrations of total protein (Figure 4 and 5). 
Another explanation of this intense reactivity may result from the high affinity of our 
antibodies to their ligands.  
Apoptosis, or programmed cell death, is a physiological death essential for 
normal development and maintenance of homeostasis (Yonehara, 2002). 
Biochemical changes in chromatin and DNA degradation provide useful and often 
quantifiable means of detecting apoptosis. Besides DNA degradation, exteriorization 
of phosphotidylserine on plasma membrane occurs during apoptosis. This change 
allows binding of the anticoagulant protein annexin V to phospholipids with a great 
affinity (Studzinski et al., 1999). This feature serves to detect and discriminate 
apoptosis from other cell death types. Another detection method is TUNEL assay 
(TdT-mediated conjugated dUTP nick end-labeling). DNA fragmentation is 
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considered to be a key event to detect apoptosis (DNA fragmentation assay); 
however, this method is not used to evaluate apoptosis in relation to histological 
localization and this obstacle may be overwhelmed  by TUNEL assay. 
Apoptosis can be activated by a number of extrinsic or intrinsic signals. In 
various apoptosis induction conditions performed during this study, protein ligands 
of  9C11 and 6D5 showed similar pattern in terms of the regulation of  expression. 
Such observation derived from both western blot and immunostaining experiments in 
which  differential expression of target proteins was detected in early and late phases 
of apoptosis. When apoptosis was induced with UV-C, down regulation of 9C11 
protein occurred starting from the 2nd hour up to 8th hour, and its expression was 
recovered at 16th after treatment lasting up to 24th hour (Figure 10). In UV-induction 
assays performed with 6D5 antibody, the same protein expression pattern was 
observed, as being a down-regulation in early phase and up-regulation in late phase 
of apoptosis (Figure 11).  
The same protein expression pattern was also observed when we induced 
apoptosis by culturing cells in serum-free medium (Figure 13, 14) and serum 
starvation followed by the treatment of cells with 100 µM of H2O2 (Figure 17, 18).  
One explanation for all of these observations might be the loss of apoptotic cells in 
the late phases of apoptosis and harvesting only cells bypassing cell death. In that 
case, the latter cells  would be compared with non-apoptotic control cells and this 
would mislead us to the conclusion that protein expression was recovered in final 
stages of apoptosis in our experimental conditions. However this was not the case, at 
least in UV-induced apoptosis experiments, since we detected  up-regulation of late 
apoptotic proteins when compared with untreated controls. Moreover, when we 
examined the morphology of cells under microscope and performed Annexin V assay 
with these cells, we observed that the ratio of apoptotic cells increased significantly 
at times most distant from the start point of experiments (Figure 12). These two 
observations constitute another evidence confirming that we collected apoptotic cells 
as expected and compared them with non-apoptotic controls. However, when 
oxidative stress condition was established by simply adding 500 µM of H2O2, a 
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gradual decrease in the signal intensity of proteins was detected in experiments 
accomplished with both antibodies (Figure 15, 16) without any recovery of protein 
expression.    
Although the transcriptional regulation of apoptosis has been extensively 
studied (Fritz et al., 1999), data explaining its translational regulation were missing. 
Recent studies clearly indicated that inhibition of protein synthesis in apoptotic 
processes is due to endoplasmic reticulum (ER) stresses resulting in unfolded protein 
response (UPR). UPR consists of the activation of transcription allowing the 
expression of components that protect cells from stress (Kaufman et al., 2002). 
Meanwhile, a transient translation attenuation of protein synthesis is also observed. 
Studies reported that this inhibition is coupled to the phosphorylation of eukaryotic 
translation initiation factor 2 (eIF2α), reducing the frequency of AUG codon 
recognition (Kaufman et al., 2002). The role of activated caspase in translation 
inhibition has been also questioned in another study (Marissen et al., 2000). These 
authors demonstrated that eIF2α and another translation initiation factor (eIF4GI) 
were targets of the caspase 3 and that caspase inhibitor might prevent protein 
synthesis inhibition. The same group also showed that translation might continue up 
to 24 hours after treatment of cells with DNA damaging agents. This issue is 
especially important for us, since we detected a translational activity in the late phase 
of apoptosis. Moreover, one should also note that generalized translation attenuation 
upon various stress stimuli inhibits anti-apoptotic proteins, whereas UPR-dependent 
transcriptional activity induces the expression of pro-apoptotic ones. This dual 
regulatory mechanism assures the progression of apoptosis process in cells through 
either extrinsic or intrinsic apoptotic pathways.  
However, despite the presence of accumulating data, the mechanism 
underlying protein synthesis inhibition in apoptosis has been partly elucidated and a 
multifactorial causality has been suggested.  
In our experimental approaches, oxidative stress induction with 500 µM of 
H2O2 failed to display a translational activity in the late phase of apoptosis, but 
rather, a gradual decrease in the expression of proteins was detected. This could be 
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due  to the insufficiency of that stimulus for cells to induce apoptosis, since we could 
not observe morphologically  any apoptotic phenotype. Another explanation might 
be the relatively late action of the stimulatory agent on cells for apoptosis induction, 
since we ended the experiment at 24th hour after treatment. 
In conclusion, we proceeded in the characterization of two monoclonal 
antibodies in the context of apoptosis and found in all designed experiments a protein 
down-regulation in  the early phases of cell death process. In contrast, a translational 
activity and to some extent an up-regulation of proteins recognized by our antibodies 
were observed in the late phases, except the case of oxidative stress induction with 
500  µM of H2O2, where a gradual protein down-regulation persisted throughout the 
assay. Furthermore, we sought the validity of  our western blot data by performing 
immunofluorescence and immunoperoxidase staining experiments, in which cells 
were subjected to the same assay conditions as western blot studies. These latter 
assays also revealed that both antibodies recognize proteins at the perinuclear zone of 
Huh-7 cells, leading us to speculate ER localization. 
These works should continue with the complete characterization of these 
two antibodies. The most direct way to accomplish this task is to identify the amino 
acid sequence of proteins recognized by 9C11 and 6D5. This could be done either by 
N-terminal amino acid sequencing (Edman Degradation) or by subjecting purified 
ligand fragments to Liquid Chromatography-Mass Spectrometry (LC-MS), which 
would follow a protein database search through identified amino acid sequence of 
peptide fragments. Then, the differential expression of proteins might be evaluated in 
apoptotic processes and the value of our antibodies as novel apoptotic markers might 
be assessed. Once characterized, another valuable approach to study apoptosis would 
be the investigation of the transcriptional regulation of these ligands.  
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Finally, agonistic and antagonistic effects of these antibodies to induce or to 
prevent apoptosis, respectively would be of great importance, since many such 
antibodies were introduced into clinical trials for the treatment of cancers and 
degenerative diseases. 
 
60 
 
 
 
 
 
REFERENCES 
 
 
 
 
 
Abbas AK and Lichtman AH Cellular and Molecular Immunology. Elsevier 
Science. 2003, Saunders Company, fifth edition, 45. 
 
Adams J and Cory S: The Bcl-2 protein family: arbiters of cell survival. Science 
1998, Aug 28; 281(5381): 1322-6. 
 
Avi Ashkenazi.Targeting Death and Decoy Receptors of the tumour-necrosis 
factor superfamily. Nat Rev Cancer 2002, 2(6): 420-30 
 
Breedveld FC: Therapeutic monoclonal antibodies. Lancet 2000, 355: 735-40 
Berna S. Sayan, Gulayse Ince, A. Emre Sayan, and Mehmet Ozturk: NAPO as a 
Novel Marker for Apoptosis.The Journel of Cell Biology 2001, 155(5): 719-724. 
 
Chen CJ, Yu MW, Liaw YF.Epidemiological characteristics and risk factors of 
hepatocellular carcinoma. J Gastroenterol Hepatol 1997, 12(9-10): S294-308. 
 
Degterev A, Boyce M, Yuan: A decade of caspases. Oncogene, 2003 24; 
22(53):8543-67. 
 
Deveraux QL, Reed JC: IAP family proteins-suppressors of apoptosis Genes Dev 
1999,  13:239-252 
 
Dominguez-Malagon H, Gaytan-Graham S: Hepatocellular carcinoma: an update. 
Ultrastruct Pathol 2001, 25(6): 497-516. 
 
  
 
61 
Durr R, Caselmann WH: Carcinogenesis  of primary liver malignancies. 
Langenbecks Arch Surg 2000, 385 (3): 154-61. 
 
DW. Nicholson: Caspase structure, proteolytic substrates, and function during 
apoptotic cell death. Cell death and differentiation 1999, 6: 1028-1042. 
 
Esma Yolcu, Berna Sayan, Tamer Yağcı, Rengül Çetin Atalay, Thierry Soussi, 
Nevzat Yurdusev and Mehmet Öztürk: A monoclonal antibody against DNA 
binding helix of p53 protein. Oncogene 2001, 20: 1398-1401. 
 
Fritz, G., and Kaina, B:  Ultraviolet Light Inhibits Translation through Activation 
of the Unfolded Protein Response Kinase PERK in the Lumen of the 
Endoplasmic Reticulum Mol. Cell. Biol. (1999) 19, 1768–1774 
 
Fulda,S.,Meyer,E.,Friesen,C.,Susin,S.A., Kroemer,G., and Debatin,K.M..Cell type 
spesific involvement of death receptor and mitochondrial pathways in drug 
induced apoptosis.Oncogene 2002,  20: 1063-1075. 
 
Gavrieli,Y.,Sherman, Y. And Ben Sasson, S.A: Identification of programmed cell 
death in situ via specific labeling of nuclear DNA fragmentation. J. Cell. Biol. 
1992, 119,  493. 
 
George P Studzinski: Apoptosis A Practical approach.Oxford University Press 
1999,  6;157. 
 
Green,D.R: Apoptotic pathways:paper wraps stone blunts scissors.Cells 200, 102: 
1-4. 
 
Hockenbery DM,Oltvaı ZN, Yin XM,Milliman CL,Korsmeyer SK: Bcl-2 
functions in an antioxidant pathway to prevent apoptosis.Cell 1993,  75:241-251. 
 
Hoffmann, P. M. Jiméne-Diaz, J. Weckesser, W.G. Bessler:  Murine bone 
marrow-derived macrophages constitute feeder cells for human B cell hybridomas. 
 
62 
J Immuno Methods 1996, 196: 85-91. 
 
Jaattela M,Wissing D, Kokholm K,Kallunki T, Egeblad M.Hsp70 exerts its anti-
apoptotic function downstrean of  caspase-3-like proteins  EMBO J  1998, 17: 
6124-6134 
 
Jun-Hwan Yoon, Gregory J. Gores Death receptor-mediated apoptosis and the 
liver. Journal of Hepatology 2002, 37: 400-410 
 
Kerr JFR, Wyllie AH and Currie AR: Apoptosis: a basic biological phenomenon 
with wide-ranging implications in tissue kinetics. Br. J. Cancer 1972, 26:239-257 
 
Klaus Schulze-Osthoff,Davide Ferrari: Apoptosis signaling by death receptors. 
Eur.J.Biochem 1998, 254: 439-459 
 
L Stergiou and MO Hengartner.Death and more: DNA damage response pathways 
in the nematode C.elegans. Cell Death and Differentiation 2004, 11: 21-28. 
 
Li JI , Chung-Yang Huang, Rong-Liang Zheng, Kai-Rong Cui and Jian-Feng 
Li.Hydrogen Peroxide induces apoptosis in human hepatoma cells and alters cell 
redox status. Cell Biology International 2000, 24: 19-23. 
 
Marian Miller, Anastasia Andringa. Insight into UV-induced 
apoptosis:Ultrastructure, trichrome stain and spectral imaging. Micron 33 2002,  
157-166 
 
Nelson PN, Reynolds GM, Waldrone EE, Ward L, Giannopoulos K, Murray PG: 
Monoclonal antibodies J Clin Pathol: Mol Pathol  2000, 53: 111-7 
 
Nesrin Özören and Wafik S.  El-Deiry. Defining Characteristics of Type I and II 
Apoptotic Cells  in response to TRAIL .Neoplasia 2002, 4 (6) 551-557. 
 
63 
 
Rajeev Goel and K. L. Khanduja: Oxidative stress-induced  apoptosis – An 
overview. Banner 1998, 75: 1338. 
 
Randal J. Kaufman, Donalyn Scheuner, Martin Schröder, Xiaohua Shen, 
Kyungho Lee, Chuan Yin Liu & Stacey M. Arnold.The Unfold Protein Response 
in Nutrient Sensing and Differentiation. Molecular Cell Biology 2002, 3: 411-421 
 
Reed J: Bcl-2 family proteins. Oncogene 1998, 17:3225-3236 
 
Richard E. Lloyd: Identification of Caspase 3-mediated Cleavage and Functional 
Alteration of Eukaryotic. Initiation Factor 2 in Apoptosis. J Biol Chem2000, 
275(13) 9314-9323. 
 
 Richter C: Pro-oxidants and mitochondrial Ca2+: their relationship to apoptosis 
and oncogenesis. FEBS Lett.  1993, 28; 325(1-2): 104-7.  
 
Shaliaja Kakibhatla and Ben Tseng: Why target apoptosis in Cancer Treatment? 
Molecular Cancer Therapeutics 2003,  2: 573-580. 
 
Shin Yonehara: Death receptor Fas and autoimmunedisease: from the original 
generation to the therapeutic application of agonistic anti-Fas monoclonal 
antibody. Cytokine and Growth Factor Reviews 2002, 13: 393-402. 
 
Sudhir Gupta: Molecular steps of death receptor and mitochondrial pathways of 
apoptosis. Life Sciences 2002, 69: 2957-2964 
 
Wilfred E. Marissen, Yanwen Guo, Adri A. M. Thomas, Robert L. Matts, and 
Martin Zörnig,Anne-Odile Hueber.Apoptosis regulators and their role in 
tumorigenesis.Biochimica et Biophysica Acta 2001, 1551:  F1-F37. 
 
64 
 
Wyllie  AH: Glucocorticoid-induced thymocyte apoptosis is associated with 
endogenous endonuclease activation.Nature 1980, 284:555-556 
 
 
 
 
 
 
 
 
 
 
